MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
MDT Medtronic
- 81.030
- +1.040+1.30%
Close Dec 20 16:00 ET
- 81.030
- 0.0000.00%
Post 20:01 ET
103.90BMarket Cap24.78P/E (TTM)
81.265High79.800Low10.71MVolume79.870Open79.990Pre Close865.83MTurnover0.84%Turnover Ratio29.36P/E (Static)1.28BShares92.68052wk High2.14P/B103.73BFloat Cap75.36552wk Low2.78Dividend TTM1.28BShs Float122.967Historical High3.43%Div YieldTTM1.83%Amplitude9.121Historical Low80.863Avg Price1Lot Size
About Medtronic Company
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Company Profile
SymbolMDT
Company NameMedtronic
Listing DateNov 21, 1977
Founded2014
CEOMr. Geoffrey S. Martha
MarketNYSE
Employees95000
Fiscal Year Ends04-25
AddressParkmore Business Park West,Building Two
CityGalway
ProvinceGA
CountryIreland
Zip Code2
Phone353-1-438-1700
Websitehttp://www.medtronic.com
Company Executives
- Name
- Position
- Salary
- Geoffrey S. Martha
- Chief Executive Officer and Chairman of the Board
- 20.08M
- Jennifer M. Kirk
- Senior Vice President, Global Controller and Chief Accounting Officer
- --
- Gary Corona
- Interim Chief Financial Officer
- --
- Sean M. Salmon
- Executive Vice President and President, Cardiovascular Portfolio
- 6.55M
- Ivan K. Fong
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Brett A. Wall
- Executive Vice President and President, Neuroscience Portfolio
- 6.44M
- Gregory L. Smith
- Executive Vice President, Global Operations and Supply Chain
- 7.66M
- Michael Marinaro
- Executive Vice President and President, Medical Surgical Portfolio and Surgical Operating Unit
- --
- Lidia L. Fonseca
- Independent Director
- 350.06K
- Kendall J. Powell
- Independent Director
- 350.06K
- Dr. Andrea J. Goldsmith, PhD
- Independent Director
- 370.06K
- Craig Arnold
- Lead Independent Director
- 410.06K
- Denise M. O'Leary
- Independent Director
- 375.06K
- Kevin E. Lofton
- Independent Director
- 370.06K
- Dr. Elizabeth G. Nabel, M.D.
- Independent Director
- 370.06K
- Gregory P. Lewis
- Independent Director
- 306.97K
- Scott C. Donnelly
- Independent Director
- 365.06K
- Randall J. Hogan, III
- Independent Director
- 385.06K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
